In this article, we will discuss the 5 Best Up and Coming Penny Stocks to Buy Now. For deeper discussion and analysis, read 8 Best Up and Coming Penny Stocks to Buy Now.
5. Richtech Robotics Inc. (NASDAQ:RR)
Stock Price: $3.02
On May 7, Richtech Robotics Inc. (NASDAQ:RR) announced a prospective partnership with SoundHound AI (SOUN), entering into a non-binding letter of intent regarding a strategic collaboration. The proposed partnership would integrate SoundHound’s advanced agentic voice AI technology into Richtech’s robotic systems, enabling more natural and responsive human-robot interactions across hospitality and service environments. The initial phase includes a demonstration featuring Richtech’s Scorpion robot paired with SoundHound’s voice AI capabilities in an interactive beverage service application.
Earlier, on April 8, Richtech Robotics Inc. (NASDAQ:RR) announced a distribution agreement with Netherlands-based NewConsultancy. Under the arrangement, NewConsultancy will distribute Richtech’s robotic solutions throughout the Netherlands and the broader European Union and Schengen region, providing local deployment, service, and customer support capabilities that expand the company’s international reach and commercialization opportunities.
Richtech Robotics Inc. (NASDAQ:RR) develops, manufactures, and deploys AI-powered service and industrial robots designed to automate labor-intensive tasks across multiple industries. Its product portfolio includes robotic food runners, autonomous cleaning systems, robotic bartenders, and AI-enabled service robots aimed at improving efficiency and addressing labor shortages. The company is headquartered in Las Vegas, Nevada, was founded in 2016, and became publicly traded in 2023.
4. Caribou Biosciences, Inc. (NASDAQ:CRBU)
Stock Price: $2.36
Caribou Biosciences, Inc. (NASDAQ:CRBU) attracted renewed attention after H.C. Wainwright analyst Robert Burns increased his price target on the stock to $11 from $9 on May 11 while maintaining a Buy rating following the company’s first-quarter results. The revised target reflects growing confidence in Caribou’s development pipeline and clinical progress, highlighting the potential value investors could realize if the company continues to execute on its strategic and operational objectives.
Earlier, on March 31, Caribou Biosciences, Inc. (NASDAQ:CRBU) announced that the U.S. Food and Drug Administration had granted Regenerative Medicine Advanced Therapy (RMAT) designation to CB-011 for the treatment of relapsed or refractory multiple myeloma. CB-011 is an allogeneic anti-BCMA CAR-T cell therapy currently being evaluated in the ongoing Phase 1 CaMMouflage clinical trial. The RMAT designation is intended to expedite the development and review of promising regenerative medicine therapies and represents an important regulatory milestone that could help accelerate the program’s path toward commercialization.
Caribou Biosciences, Inc. (NASDAQ:CRBU) is a clinical-stage biopharmaceutical company headquartered in Berkeley, California, and was founded in 2011. The company focuses on developing next-generation, off-the-shelf CRISPR-edited cell therapies for patients with cancer and autoimmune diseases. The company completed its initial public offering in 2021.
3. Olaplex Holdings, Inc. (NASDAQ:OLPX)
Stock Price: $2.04
Olaplex Holdings, Inc. (NASDAQ:OLPX) delivered a stronger-than-expected start to the year, reporting first-quarter revenue of $99.4 million on May 11, ahead of the $94.03 million consensus estimate. Chief Executive Officer Amanda Baldwin highlighted positive sell-through trends during the quarter, driven by the successful launch of No. 3 PLUS and supported by disciplined execution of the company’s ongoing transformation strategy. Management emphasized that improved sales performance translated into solid financial results, underscoring the effectiveness of initiatives aimed at strengthening the brand and improving operational efficiency.
Investor sentiment also received support on April 23 when TD Cowen increased its price target on Olaplex Holdings, Inc. (NASDAQ:OLPX) to $2.06 from $1.40 while maintaining a Hold rating. The adjustment followed news of the company’s agreement to be acquired by Henkel, a development that has attracted significant market attention. The transaction reflects the strategic value of the Olaplex brand and its intellectual property portfolio, while also highlighting the company’s position within the premium hair-care market.
Olaplex Holdings, Inc. (NASDAQ:OLPX) is a prestige hair-health company headquartered in New York City and was founded in 2014. The company pioneered bond-building technology designed to repair damaged hair by reconnecting broken molecular bonds affected by chemical treatments, heat styling, and mechanical stress. The company has been headquartered in Santa Barbara, California, since completing its initial public offering in 2021.
2. Blaize Holdings, Inc. (NASDAQ:BZAI)
Stock Price: $1.76
Blaize Holdings, Inc. (NASDAQ:BZAI) remained in focus after Roth Capital analyst Scott Searle lowered his price target on the stock to $4.50 from $8.50 on May 15 while maintaining a Buy rating. Although the analyst acknowledged near-term challenges related to memory availability that affected the company’s ability to capitalize on certain opportunities, he noted that first-quarter results were in line with previously announced expectations and expressed confidence in Blaize’s longer-term growth prospects.
A day earlier, Blaize Holdings, Inc. (NASDAQ:BZAI) reported first-quarter revenue of $2.7 million, matching consensus estimates. Management outlined several developments that could support future growth, including an $11 million purchase order resulting from its NeoTensr engagement, expansion into AI cloud infrastructure through a collaboration with Nokia, and progress with Winmate that could lead to broader adoption of Blaize chips in rugged computing platforms. Chief Executive Officer Dinakar Munagala also highlighted the launch of Blaize AI Services, which introduces recurring API-based revenue opportunities and further diversifies the company’s business model.
Blaize Holdings, Inc. (NASDAQ:BZAI) is a semiconductor and software company headquartered in El Dorado Hills, California. Founded in 2010, the company develops full-stack Hybrid AI computing solutions and low-code/no-code software platforms designed to accelerate AI inference workloads across data centers and edge computing environments. Blaize became a publicly traded company in 2025.
1. Zevia PBC (NYSE:ZVIA)
Stock Price: $1.55
Zevia PBC (NYSE:ZVIA) came under pressure after Telsey Advisory analyst Dana Telsey reduced her price target on the stock to $3 from $5 on May 7 while maintaining a Market Perform rating. The analyst described the company’s first-quarter results as mixed, noting that revenue declined roughly 10% year over year and adjusted EBITDA came in weaker than expected. Concerns were also raised about the company’s near-term execution, with the firm suggesting that improvements in go-to-market strategy and operational performance will be necessary to support stronger growth.
The day before, Zevia PBC (NYSE:ZVIA) provided updated financial guidance that fell below market expectations. Management forecast full-year net sales of between $158 million and $166 million and projected second-quarter revenue in the range of $38 million to $40 million, compared with analyst consensus estimates of $46.33 million. While the outlook reflects a cautious near-term operating environment, it also provides investors with greater visibility into management’s expectations as the company works through current business challenges.
Zevia PBC (NYSE:ZVIA) is a beverage company headquartered in Encino, California, and was founded in 2007. The company specializes in zero-calorie beverages sweetened with natural ingredients, offering a portfolio that includes sodas, energy drinks, teas, and other better-for-you drink options. The company expanded its public market presence through its initial public offering in 2021.
While we acknowledge the potential of ZVIA as the best up and coming penny stock, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ZVIA and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 12 Best Future Stocks to Buy Right Now and 9 Best Space Stocks to Buy According to Reddit and Social Media.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
